We appreciated Telit’s assistance and support in the certification of our product for a global market.
– Ricci Marshall, Owner and Director
According to research published in the New England Journal of Medicine, between 43 and 78% of patients are non-adherent. Further research from Osterberg and Blaschke (2005) shows that of all the medication-related hospital admissions in the United States, 33 to 69% were due to poor medication adherence, with results in approximately $100 billion a year in healthcare costs.
Husband and wife team, Lloyd and Ricci Marshall, founded Wisepill Technologies in 2007 to address the issue of medication non-adherence in both developed and developing countries. The company designed the Wisepill electronic pillbox in order to help monitor patient adherence and provide instant feedback through cellular and Internet technology.
The Wisepill dispenser was designed to be wireless, portable, and affordable. The company also wanted their product to be able to be used internationally. Using Telit’s GE864-QUAD module, the company was able to achieve all these goals.
The Wisepill dispenser is a pillbox with a GSM communication chip at its core, which uses cellular phone and Internet technologies to provide real-time medication management. In addition, performance can be monitored on the Wisepill website. Email or SMS reminders can also be sent to patients and caregivers if doses are missed.
The Wisepill device and services are now widely available to pharmaceutical businesses and health care organizations, offering an effective tool to help patients improve their medication adherence and, ultimately, their health.
In 2010, Family Health International chose the Wisepill dispenser to be used in their Truvada Clinical Trials. This was the first time that anti-retroviral drugs were used as a pre-exposure prophylaxis treatment for high-risk HIV patients. In 2011, Wisepill went on to win the South African Department of Trade and Industries Technology Award for small businesses.
To date, the Wisepill dispenser has been used in many countries by patients living with Tuberculosis, HIV, Epilepsy, Osteoporosis, Chronic Heart conditions, Diabetes, Leukemia, Asthma, ADHD and Hepatitis C.
The system has also been used by research organizations and universities to monitor adherence for research purposes. In addition, Wisepill has partnered with Massachusetts General Hospital and the Harvard Initiative for Global Health to adapt the technology for rural environments where cellular coverage is not always reliable.
Take Your Healthcare IoT Solutions Global
The IoT experts at Telit can help you get your healthcare IoT solutions ready for the global market.